Literature DB >> 15046649

Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment.

Seung-Ki Kim1, Ho Jun Seol, Byung-Kyu Cho, Yong-Seung Hwang, Dong Soo Lee, Kyu-Chang Wang.   

Abstract

OBJECTIVE: The prognosis for moyamoya disease (MMD) among young patients is known to be worse than that among older patients. The aim of this study was to investigate the clinical features and treatment outcomes of young patients with MMD.
METHODS: A total of 204 patients with MMD who underwent encephaloduroarteriosynangiosis, with or without bifrontal encephalogaleosynangiosis, were categorized into three groups according to their ages at the time of surgery, i.e., Group A (n = 23, <3 yr of age), Group B (n = 50, 3-6 yr of age), and Group C (n = 131, >6 yr of age). For each group, patterns of presentation and the occurrence of subsequent preoperative or surgery-related infarctions were assessed. Clinical outcomes and postoperative hemodynamic status were analyzed.
RESULTS: At initial presentation, infarctions were significantly more frequent in Group A (87%) and Group B (58%) than in Group C (46%). Subsequent preoperative infarctions occurred significantly more frequently in Group A (39%) than in Group B (6%) or Group C (0.8%). The median interval between the onset of symptoms and a subsequent preoperative infarction was 3 months (range, 1-14 mo). No significant difference in the rates of surgery-related infarctions among the three groups was observed. The rate of favorable clinical outcomes was significantly lower in Group A (58%) than in Group B (84%) or Group C (86%), although the rates of postoperative hemodynamic improvements were similar among the groups. The poor clinical outcomes for Group A were caused mainly by preoperative infarctions.
CONCLUSION: Young-age MMD demonstrates rapid disease progression and results in poor clinical outcomes. These findings indicate the necessity of early surgery for young patients with MMD; however, the actual benefits should be verified with additional controlled studies, with long-term follow-up monitoring.

Entities:  

Mesh:

Year:  2004        PMID: 15046649     DOI: 10.1227/01.neu.0000114140.41509.14

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  32 in total

1.  Quantitative Assessment of Neovascularization after Indirect Bypass Surgery: Color-Coded Digital Subtraction Angiography in Pediatric Moyamoya Disease.

Authors:  H-H Cho; J-E Cheon; S-K Kim; Y H Choi; I-O Kim; W S Kim; S-M Lee; S K You; S-M Shin
Journal:  AJNR Am J Neuroradiol       Date:  2015-12-17       Impact factor: 3.825

2.  Unilateral (probable) moyamoya disease: long-term follow-up of seven cases.

Authors:  Ho Jun Seol; Kyu-Chang Wang; Seung-Ki Kim; Chang Sub Lee; Dong Soo Lee; In-One Kim; Byung-Kyu Cho
Journal:  Childs Nerv Syst       Date:  2005-10-12       Impact factor: 1.475

3.  Posterior cerebral artery involvement in moyamoya disease: initial infarction and angle between PCA and basilar artery.

Authors:  Ji Yeoun Lee; Seung-Ki Kim; Jung-Eun Cheon; Jung Won Choi; Ji Hoon Phi; In-One Kim; Byung-Kyu Cho; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2013-05-08       Impact factor: 1.475

4.  Moyamoya complicated by thrombotic cerebrovascular accident in a Caucasian woman with collagenous colitis.

Authors:  Manshi Valluri; Hossein Akhondi; Mark Hyndman
Journal:  Neurol Sci       Date:  2018-08-09       Impact factor: 3.307

5.  Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Masaki Sumitomo; Sho Okamoto; Kota Matsui; Ryo Emoto; Toshihiko Wakabayashi; Shigeyuki Matsui; Atsushi Natsume
Journal:  Neurosurg Rev       Date:  2021-01-08       Impact factor: 3.042

6.  Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.

Authors:  Ramin A Morshed; Adib A Abla; Daniel Murph; Jasmin M Dao; Ethan A Winkler; Jan-Karl Burkhardt; Kathleen Colao; Steven W Hetts; Heather J Fullerton; Michael T Lawton; Nalin Gupta; Christine K Fox
Journal:  J Clin Neurosci       Date:  2020-08-19       Impact factor: 1.961

7.  Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels.

Authors:  Takeshi Sawada; Akira Yamamoto; Yukio Miki; Ken-Ichiro Kikuta; Tomohisa Okada; Mitsunori Kanagaki; Seiko Kasahara; Susumu Miyamoto; Jun C Takahashi; Hidenao Fukuyama; Kaori Togashi
Journal:  Neuroradiology       Date:  2012-02-21       Impact factor: 2.804

8.  CT perfusion assessment of Moyamoya syndrome before and after direct revascularization (superficial temporal artery to middle cerebral artery bypass).

Authors:  Yueqin Chen; Wenjian Xu; Xiang Guo; Zhitao Shi; Zhanguo Sun; Lingyun Gao; Feng Jin; Jiehuan Wang; Weijian Chen; Yunjun Yang
Journal:  Eur Radiol       Date:  2015-05-01       Impact factor: 5.315

9.  Early-onset stroke with moyamoya-like syndrome and extraneurological signs: a first reported paediatric series.

Authors:  Bruno Law-Ye; Guillaume Saliou; Frédérique Toulgoat; Marc Tardieu; Kumaran Deiva; Catherine Adamsbaum; Béatrice Husson
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

Review 10.  Moyamoya disease: a clinical spectrum, literature review and case series from a tertiary care hospital in Pakistan.

Authors:  Sana Shoukat; Ahmed Itrat; Ather M Taqui; Moazzam Zaidi; Ayeesha K Kamal
Journal:  BMC Neurol       Date:  2009-04-15       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.